Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT00243776
- Status
- Recruiting
Conditions
- Congenital Heart Disease
- Tetralogy of Fallot
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 20 Years
- Healthy Volunteers
- Not accepted
Study Details
The study team will use small pieces of human hearts which are removed as part of a required surgical procedure to study different objectives. One of the objective is how calcium ions pass through the membrane of heart cells in order to tell the heart cell how much force to contract with when the heart beats. Investigators will also study the proteins and RNA of these pieces to determine how the newborn heart cells control their force of contraction differently from adult heart cells. Investigators hypothesize that infant hearts have different regulation of calcium entry than adult hearts. The study team also wants to study combinations of 3D cardiac spheres with multiple environmental cues that can improve functional and metabolic maturation of Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and generate a more clinically relevant cell model.
Key Dates
- Start date
- Apr 30, 2005
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 600 participants (estimated)
Arms
- Arm: Cardiac TissueCardiac tissue and cells will be obtained from participants undergoing cardiac surgical repair
Primary Outcome Measure
Calcium Current Measures [ Time Frame: Duration of Study (Up to 13 Years) ]
Central Contacts
- Michael E Davis, PhD404-727-9858
- Kati Miller404-729-0492
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory University School of Medicine | Atlanta | Georgia | 30322 | Mary B Wagner, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Atlanta, GA
Related Studies
- Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease TreatmentRecruiting · Columbia University · Gainesville, Florida
- HFNC vs NIPPV Following ExtubationRecruiting · Emory University · Atlanta, Georgia
- Autus Valve Continued Access Study (CAS)Not Yet Recruiting · Autus Valve Technologies, Inc. · Los Angeles, California
- Genetics of Congenital Heart DiseaseRecruiting · Nationwide Children's Hospital · Columbus, Ohio